Hennion & Walsh Asset Management’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2M Buy
276,696
+93,192
+51% +$2.53M 0.29% 69
2026
Q1
$3.3M Buy
183,504
+21,580
+13% +$433K 0.11% 239
2025
Q4
$3.79M Buy
161,924
+96,741
+148% +$2.1M 0.13% 198
2025
Q3
$1.3M Buy
65,183
+26,828
+70% +$482K 0.05% 451
2025
Q2
$525K Buy
+38,355
New +$368K 0.02% 656

Other funds holding URGN